Literature DB >> 11174629

Molecular characterization of a pediatric pheochromocytoma with suspected bilateral disease.

H Mircescu1, F Wilkin, J Paquette, L L Oligny, H Decaluwe, L Gaboury, S Nolet, G Van Vliet, C Deal.   

Abstract

An 11-year-old boy with hypertension was suspected of having bilateral adrenal pheochromocytomas and hyperplasia. Molecular analysis of specific tumor suppressor genes and oncogenes excluded the familial syndromes, von Hippel-Lindau (VHL) disease and multiple endocrine neoplasia (MEN) type 2A. Further evaluation identified a unilateral adrenal pheochromocytoma with a VHL heterozygous somatic mutation (G695A) and loss of the maternal allele at 11p15.5-11p14 exclusively in the tumor tissue. Both reverse-transcriptase polymerase chain reaction and immunohistochemistry confirmed increased expression of IGF2 within the tumoral tissue, relative to a normal control adrenal gland. These results ruled out familial syndromes and suggested that the VHL mutation and the loss of maternal allele on chromosome 11 could have contributed to tumor development.

Entities:  

Mesh:

Year:  2001        PMID: 11174629     DOI: 10.1067/mpd.2001.111316

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  5 in total

1.  Bilateral pheochromocytomas, hemihyperplasia, and subtle somatic mosaicism: the importance of detecting low-level uniparental disomy.

Authors:  Jennifer M Kalish; Laura K Conlin; Sogol Mostoufi-Moab; Alisha B Wilkens; Surabhi Mulchandani; Kristin Zelley; Megan Kowalski; Tricia R Bhatti; Pierre Russo; Peter Mattei; William G Mackenzie; Virginia LiVolsi; Kim E Nichols; Jaclyn A Biegel; Nancy B Spinner; Matthew A Deardorff
Journal:  Am J Med Genet A       Date:  2013-03-26       Impact factor: 2.802

Review 2.  Recent advances in the genetics of SDH-related paraganglioma and pheochromocytoma.

Authors:  Erik F Hensen; Jean-Pierre Bayley
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

3.  Germline mutations in the new E1' cryptic exon of the VHL gene in patients with tumours of von Hippel-Lindau disease spectrum or with paraganglioma.

Authors:  Bruna Calsina; Shahida Flores; Sophie Giraud; Marion Lenglet; Alexandre Buffet; Pauline Romanet; Elisa Deflorenne; Javier Aller; Isabelle Bourdeau; Brigitte Bressac-de Paillerets; María Calatayud; Caroline Dehais; Erwan De Mones Del Pujol; Atanaska Elenkova; Philippe Herman; Peter Kamenický; Sophie Lejeune; Jean Louis Sadoul; Anne Barlier; Stephane Richard; Judith Favier; Nelly Burnichon; Betty Gardie; Patricia L Dahia; Mercedes Robledo; Anne-Paule Gimenez-Roqueplo
Journal:  J Med Genet       Date:  2020-01-29       Impact factor: 6.318

4.  The first Dutch SDHB founder deletion in paraganglioma-pheochromocytoma patients.

Authors:  Jean-Pierre Bayley; Anneliese E M Grimbergen; Patrick A van Bunderen; Michiel van der Wielen; Henricus P Kunst; Jacques W Lenders; Jeroen C Jansen; Robin P F Dullaart; Peter Devilee; Eleonora P Corssmit; Annette H Vriends; Monique Losekoot; Marjan M Weiss
Journal:  BMC Med Genet       Date:  2009-04-15       Impact factor: 2.103

5.  Paraganglioma and pheochromocytoma upon maternal transmission of SDHD mutations.

Authors:  Jean-Pierre Bayley; Rogier A Oldenburg; Jennifer Nuk; Attje S Hoekstra; Conny A van der Meer; Esther Korpershoek; Barbara McGillivray; Eleonora P M Corssmit; Winand N M Dinjens; Ronald R de Krijger; Peter Devilee; Jeroen C Jansen; Frederik J Hes
Journal:  BMC Med Genet       Date:  2014-10-10       Impact factor: 2.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.